Physician
Riverside Physician Services, INC.
Riverside Physician Services, INC. was paid $44.72M by Medicaid between Jan 2018 and Dec 2024, across 272 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoRIVERSIDE PHYSICIAN SERVICES, INC.
NEWPORT NEWS, VA 23601
NEWPORT NEWS, VA 23601
33aNPI1710020623assigned 02/14/2007
33bProvider typeAnesthesiology Physician
28Total paid$44.72M
24GClaims1,183,081
24DCodes billed272
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Virginia
Rank by total paid#1 of 61
Median peer was paid$20K
This provider vs. median2,278×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 100,239 | $2.19M | |
| 2019 | 166,076 | $4.89M | |
| 2020 | 153,774 | $5.87M | |
| 2021 | 178,878 | $7.19M | |
| 2022 | 189,185 | $8.17M | |
| 2023 | 217,505 | $9.30M | |
| 2024incomplete | 177,424 | $7.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 271,011 | 251,358 | $16.51M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 171,028 | 157,097 | $7.74M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.3% | 20,652 | 20,114 | $1.92M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.2% | 56,635 | 21,560 | $1.89M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 3.2% | 2,332 | 1,364 | $1.45M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.1% | 18,604 | 17,643 | $1.40M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 16,610 | 15,840 | $776K |
| 99223 | Prolong inpt eval add15 m | 1.7% | 8,687 | 8,057 | $775K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.6% | 141,417 | 118,683 | $696K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 11,400 | 10,913 | $677K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.5% | 6,256 | 6,041 | $661K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.4% | 12,238 | 11,373 | $631K |
260 more codes
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.3% | 11,974 | $579K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 6,153 | $371K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,615 | $343K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,864 | $314K |
| 20610 | <1% | 8,860 | $313K | |
| 99221 | <1% | 6,891 | $310K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 4,197 | $308K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,245 | $307K |
| 92015 | Determination of refractive state | <1% | 20,011 | $287K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,117 | $220K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,983 | $217K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,242 | $210K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,640 | $205K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 4,571 | $201K |
| 36415 | Collection of venous blood by venipuncture | <1% | 113,212 | $192K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 10,310 | $189K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,619 | $185K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,781 | $176K |
| 90686 | <1% | 12,303 | $167K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 18,968 | $163K |
| 0002A | <1% | 4,201 | $158K | |
| 64615 | <1% | 1,589 | $157K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 163 | $155K |
| 0001A | <1% | 4,676 | $151K | |
| 20611 | <1% | 2,249 | $148K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,313 | $140K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 2,425 | $138K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 2,329 | $128K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,548 | $120K |
| 92134 | <1% | 5,558 | $111K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,422 | $108K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 12,748 | $101K |
| 99220 | <1% | 1,055 | $92K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,194 | $87K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,148 | $83K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 43 | $71K |
| 97597 | <1% | 3,489 | $69K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,167 | $67K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,171 | $64K |
| 76830 | Ultrasound, transvaginal | <1% | 639 | $63K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 945 | $57K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,744 | $55K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,772 | $54K |
| D1110 | Prophylaxis - adult | <1% | 1,590 | $51K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 2,166 | $49K |
| 99217 | <1% | 1,340 | $47K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 548 | $47K |
| 92133 | <1% | 1,862 | $45K | |
| 90670 | <1% | 2,938 | $43K | |
| 93971 | <1% | 2,466 | $42K | |
| 81025 | <1% | 6,830 | $42K | |
| 95886 | <1% | 607 | $41K | |
| 59025 | Fetal non-stress test | <1% | 1,172 | $40K |
| 11056 | <1% | 4,016 | $40K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 8,448 | $37K |
| 93295 | <1% | 1,890 | $36K | |
| 76882 | <1% | 699 | $34K | |
| D0274 | Bitewings - four radiographic images | <1% | 1,643 | $33K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 341 | $33K |
| 95806 | <1% | 1,033 | $32K | |
| 95816 | <1% | 935 | $31K | |
| 99205 | Prolong outpt/office vis | <1% | 256 | $30K |
| 10060 | <1% | 1,160 | $30K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,317 | $28K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,226 | $28K |
| 95251 | <1% | 1,398 | $28K | |
| 62323 | <1% | 298 | $27K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 835 | $26K |
| 90961 | <1% | 428 | $26K | |
| 99385 | <1% | 296 | $25K | |
| 77427 | <1% | 209 | $24K | |
| 0004A | <1% | 646 | $24K | |
| 92557 | <1% | 1,006 | $24K | |
| 93970 | <1% | 1,078 | $23K | |
| 99284 | Emergency room visit (serious) | <1% | 352 | $22K |
| 94726 | <1% | 2,706 | $22K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 123 | $20K |
| 93298 | <1% | 1,402 | $20K | |
| 95885 | <1% | 411 | $19K | |
| 64616 | <1% | 170 | $19K | |
| 94729 | <1% | 2,941 | $18K | |
| 90723 | <1% | 1,316 | $17K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,965 | $16K |
| 90633 | <1% | 1,429 | $16K | |
| 99283 | Emergency room visit (moderate) | <1% | 443 | $16K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 228 | $16K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,819 | $16K |
| 99307 | <1% | 2,751 | $16K | |
| 92083 | <1% | 433 | $15K | |
| 93296 | <1% | 949 | $15K | |
| 91320 | <1% | 194 | $14K | |
| 99459 | <1% | 1,301 | $14K | |
| 93297 | <1% | 1,136 | $14K | |
| 95874 | <1% | 409 | $14K | |
| 92567 | <1% | 1,286 | $14K | |
| 90651 | <1% | 790 | $13K | |
| 97598 | <1% | 181 | $13K | |
| 94060 | <1% | 1,615 | $13K | |
| 0124A | <1% | 376 | $12K | |
| 93016 | <1% | 1,033 | $12K | |
| 85018 | <1% | 5,587 | $12K | |
| 87807 | <1% | 1,069 | $12K | |
| 90647 | <1% | 1,019 | $11K | |
| 0054A | <1% | 400 | $11K | |
| 92551 | <1% | 1,165 | $11K | |
| 92250 | <1% | 580 | $11K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,963 | $11K |
| 80061 | Lipid panel | <1% | 1,850 | $10K |
| 99386 | <1% | 116 | $10K | |
| 99188 | <1% | 532 | $10K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 80 | $9K |
| 90661 | <1% | 515 | $9K | |
| S0612 | Annual gynecological examination, established patient | <1% | 253 | $9K |
| 90672 | <1% | 846 | $9K | |
| 11721 | <1% | 1,563 | $9K | |
| 90677 | <1% | 198 | $8K | |
| 93018 | <1% | 1,026 | $8K | |
| 81002 | <1% | 3,192 | $8K | |
| 64483 | <1% | 84 | $8K | |
| 77014 | <1% | 269 | $8K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 494 | $8K |
| 0012A | <1% | 226 | $7K | |
| 90715 | <1% | 307 | $7K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 381 | $7K |
| 31575 | <1% | 102 | $7K | |
| 0011A | <1% | 263 | $7K | |
| 0071A | <1% | 168 | $7K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 386 | $6K |
| 90681 | <1% | 453 | $6K | |
| 90734 | <1% | 435 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 520 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 415 | $6K |
| 20552 | <1% | 239 | $5K | |
| 99174 | <1% | 1,004 | $5K | |
| 0072A | <1% | 126 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,488 | $5K |
| 52000 | <1% | 39 | $5K | |
| 90648 | <1% | 453 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 41 | $5K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 67 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 1,537 | $4K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 15 | $4K |
| 43235 | <1% | 63 | $4K | |
| Q3014 | Telehealth originating site facility fee | <1% | 208 | $4K |
| D0120 | Dental checkup, returning patient | <1% | 378 | $4K |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 44 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 855 | $4K |
| 93294 | <1% | 396 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 108 | $4K |
| 93000 | <1% | 385 | $4K | |
| 64493 | <1% | 38 | $4K | |
| 96158 | <1% | 125 | $4K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 1,833 | $4K |
| 90480 | <1% | 204 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 41 | $3K |
| 99225 | <1% | 98 | $3K | |
| 81003 | <1% | 2,038 | $3K | |
| 95908 | <1% | 45 | $3K | |
| 54150 | <1% | 69 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $3K |
| 92020 | <1% | 170 | $3K | |
| 96127 | <1% | 574 | $3K | |
| 81001 | <1% | 959 | $3K | |
| 99350 | Prolong home eval add 15m | <1% | 45 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 182 | $2K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 76 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 309 | $2K |
| 90710 | <1% | 196 | $2K | |
| 99406 | <1% | 490 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 277 | $2K |
| 90732 | <1% | 29 | $2K | |
| 77334 | <1% | 21 | $2K | |
| 51798 | <1% | 303 | $2K | |
| 99173 | <1% | 872 | $2K | |
| 0003A | <1% | 53 | $2K | |
| 90685 | <1% | 173 | $2K | |
| D4341 | <1% | 20 | $2K | |
| 90698 | <1% | 157 | $2K | |
| 99442 | <1% | 51 | $2K | |
| 90697 | <1% | 147 | $2K | |
| 90696 | <1% | 125 | $2K | |
| 11057 | <1% | 201 | $2K | |
| 95911 | <1% | 12 | $2K | |
| 0064A | <1% | 49 | $1K | |
| 0052A | <1% | 41 | $1K | |
| 0513F | <1% | 174 | $1K | |
| 76506 | <1% | 56 | $1K | |
| 99152 | <1% | 111 | $1K | |
| 90716 | <1% | 103 | $1K | |
| 90671 | <1% | 112 | $1K | |
| 69210 | <1% | 41 | $1K | |
| 90966 | <1% | 12 | $1K | |
| 90707 | <1% | 100 | $1K | |
| 31231 | <1% | 13 | $1K | |
| 99384 | <1% | 13 | $1K | |
| 94010 | <1% | 211 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 30 | $1K |
| 65855 | <1% | 16 | $1K | |
| 99460 | <1% | 25 | $1K | |
| 99443 | <1% | 15 | $1K | |
| 99381 | <1% | 12 | $979.68 | |
| 99383 | <1% | 12 | $978.22 | |
| 64494 | <1% | 24 | $970.52 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 38 | $920.14 |
| 3046F | <1% | 121 | $860.01 | |
| 20550 | <1% | 29 | $859.17 | |
| 92060 | <1% | 15 | $841.89 | |
| 77300 | <1% | 15 | $836.87 | |
| 20526 | <1% | 12 | $819.71 | |
| 90660 | <1% | 62 | $809.87 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 181 | $780.59 |
| 84439 | <1% | 178 | $772.14 | |
| 99243 | <1% | 14 | $757.08 | |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | <1% | 13 | $733.17 |
| 99201 | <1% | 31 | $616.29 | |
| 99421 | <1% | 61 | $590.36 | |
| 93880 | <1% | 46 | $536.84 | |
| 77002 | <1% | 56 | $499.00 | |
| 64405 | <1% | 25 | $448.05 | |
| 90662 | <1% | 58 | $409.16 | |
| 99358 | Prolong nursin fac eval 15m | <1% | 13 | $388.84 |
| 0051A | <1% | 13 | $383.36 | |
| 93922 | <1% | 37 | $350.62 | |
| 96160 | <1% | 190 | $338.11 | |
| 36416 | <1% | 3,123 | $324.64 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 328 | $322.18 |
| 82607 | <1% | 57 | $308.72 | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $307.04 |
| 90620 | <1% | 26 | $306.90 | |
| D0140 | Limited oral evaluation - problem focused | <1% | 12 | $297.96 |
| 87210 | <1% | 80 | $289.22 | |
| 85027 | <1% | 63 | $260.31 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 137 | $235.59 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $225.82 |
| 99082 | <1% | 13 | $169.08 | |
| 93325 | <1% | 92 | $162.41 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 54 | $153.60 |
| 93308 | <1% | 14 | $111.92 | |
| 82728 | <1% | 27 | $111.06 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 52 | $108.05 |
| 84481 | <1% | 13 | $99.36 | |
| 94727 | <1% | 12 | $95.48 | |
| 76937 | <1% | 15 | $89.20 | |
| 83550 | <1% | 27 | $79.72 | |
| 99441 | <1% | 18 | $65.80 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 20 | $61.20 |
| 99497 | <1% | 32 | $60.00 | |
| 80076 | <1% | 39 | $58.05 | |
| G0008 | Administration of influenza virus vaccine | <1% | 309 | $57.06 |
| 83540 | <1% | 27 | $55.13 | |
| 93244 | <1% | 12 | $49.82 | |
| 85610 | <1% | 17 | $39.74 | |
| 93321 | <1% | 14 | $36.94 | |
| 96161 | <1% | 15 | $23.45 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 202 | $17.34 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 40 | $3.76 |
| 91305 | <1% | 66 | $0.20 | |
| 1111F | 0% | 3,278 | $0.00 | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 82 | $0.00 |
| 3074F | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLESNICK, JAMES (VICE PRESIDENT)
Parent organizationRIVERSIDE HEALTHCARE ASSOCIATES INC
| Provider | Location | Paid |
|---|---|---|
| Riverside Hospital INC. | Newport News, VA | $7.74M |
| Riverside Physician Services INC | Newport News, VA | $428K |
| Peninsula Cancer Institute, LLC | Chesapeake, VA | $103K |
| Riverside Physician Services INC | Hampton, VA | $64K |
| Riverside Physician Services INC | Newport News, VA | $3K |
| Riverside Physician Services INC | Williamsburg, VA | $540.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.